Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH)
AUPH Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
38.80%
Analyst Rating:
BUY
Analyst Forecast (1yr):
7.70%
AUPH Stock Analysis
AUPH
PE Ratio:
7.3
AUPH
PEG Ratio:
0.3
AUPH
Forward EPS Growth (12 month):
28.80%
AUPH
PS Ratio:
6.8
AUPH
PSG Ratio:
0.4
AUPH
Forward Revenue Growth (12 month):
18.80%
AUPH Articles
No data was found